Oral rehabilitation with dental implants in patients with systemic sclerosis: A systematic review

Abstract

To assess the influence of systemic sclerosis (SSc) on the survival rate of dental implants in SSc patients receiving implant-supported treatments. Methods: The Preferred Reporting Items for Systematic Reviews and Metaanalysis (PRISMA) Statement and the Cochrane Collaboration's guiding principles were followed during the study's execution. The data from three databases, PubMed, Google Scholar, and Scopus, available until January 2023, were used to compile the material for our research. Only English-language publications were submitted for this research and evaluated based on their titles, abstracts, and full texts. For performing a quality assessment, quality scores were calculated. Results: The total number of patients and implants studied were 37 and 153, respectively, all having had scleroderma. The patients' ages ranged from 28 to 77 years old, with a mean (SD) age of 58.16 (12.88). All the patients in the case reports and most in the case series study were female. The range of follow-up duration was from 1 to 10 years. In case report studies, the survival rate was 100%; in case series, it was 89.2%. Conclusion:The SSc status had no discernible impact on the implant survival rate. Implant-based treatments in SSc patients should not worsen the overall morbidity and should not conflict with systemic treatments. Before starting implant therapy, a thorough risk assessment is essential, though.

Implant-supported prosthetic rehabilitation after Ameloblastomas treatment: a systematic review

“…In patients with systemic sclerosis it was 97,7% after 37,5 months. In patients with pemphigus, and systemic lupus erythematosus it was 100% after 24 months [ 88 ] Thus, it appears that the autoimmune status had no discernible impact on the survival rate of dental implants, however, a comprehensive risk assessment is recommended before starting implant therapy [ 89 ].…”

The effect of photobiomodulation therapy in common maxillofacial injuries: Current status

“…When faced with substantial tissue defects, repairing the damage can be a complex task that often requires the utilization of biomaterials, 100,101 bone substitutes, and implants. 102,103 Tissue engineering is essential in expediting the evolution of components that facilitate the reconstruction of damaged or lost tissue. Numerous studies have reported that PBMT contributes to tissue regeneration by exerting biological modulatory effects on cell differentiation, improving the healing of fractures, regenerating periodontal tissue, promoting implant osseointegration, and facilitating bone reconstruction.…”

“…While bone remodeling is generally a regulated physiological process, imbalances between bone deposition and removal can occur. When faced with substantial tissue defects, repairing the damage can be a complex task that often requires the utilization of biomaterials, 100,101 bone substitutes, and implants 102,103 . Tissue engineering is essential in expediting the evolution of components that facilitate the reconstruction of damaged or lost tissue.…”

Cross Talk Between Cells and the Current Bioceramics in Bone Regeneration: A Comprehensive Review

“…TCP and HA find widespread application in fields like orthopedics and dentistry. They are employed as coatings on metal implants 18 or in combination with other substances, earning the designation of “bioactive ceramics” because they stimulate osseointegration through specific biological responses 19 , 20 . Bioactive glass (BG) can also be incorporated into a polymeric matrix to create composite materials 21 .…”